HHS, Genentech join forces on medicines to combat influenza, other health security threats


The US Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) announced a strategic partnership with Genentech. The company and ASPR’s Biomedical Advanced Research and Development Authority (BARDA) will focus first on developing a first-in-class therapeutic for hospitalized influenza patients and a treatment for lung injuries caused by inhaling sulfur mustard gas.

Content Information

Content Author: 
unknown
Content Source: 
EIN News
Content Type: 
News